Want to track LCTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Lineage Cell Therapeutics Inc. (LCTX) Statistics
Valuation metrics
Market Cap 276.72M
Enterprise value 241.67M
Trailing P/E (ttm) -7.92
Forward P/E -
PEG ratio 0.2
Price/Sales (ttm) 21.15
Price/Book (mrq) 4.55
Enterprise Value/Revenue 18.47
Enterprise Value/EBITDA -6.59
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 766.8K
Average volume (90 days) 891.91K
Price summary
52-Week low 1
52-Week high 2.09
Beta -
50-Day moving average 1.11
200-Day moving average 1.53
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 3:1
Last split Date 31 Oct 1997
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -2.47%
Operating margin -2.05%
Operational effectiveness
Return on assets -0.3%
Return on equity -0.71%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.05
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.13
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.2
Total debt (mrq) -
Total Debt/Equity (mrq) 0.04
Current ratio (mrq) 6.61%
Book value per share (mrq) 0.24
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
